Invesco CurrencyShares Swiss Franc Trust — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Invesco CurrencyShares Swiss Franc Trust filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $458.6K | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $318.8K | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $0 | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $0 | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | $0 | Feb 28, 2020 |
| FY2019 | Dec 31, 2018 | $0 | Feb 28, 2020 |
| FY2018 | Oct 31, 2018 | $0 | Jan 11, 2019 |
| FY2018 | Jul 31, 2018 | $0 | Jan 11, 2019 |
| FY2018 | Apr 30, 2018 | $0 | Jan 11, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.69M) | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | ($158.2K) | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | ($453.2K) | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | ($2.26M) | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | ($3.12M) | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | ($2.36M) | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | ($1.72M) | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | ($348.0K) | Feb 28, 2020 |
| FY2018 | Oct 31, 2018 | ($510.0K) | Jan 11, 2019 |
| FY2018 | Jul 31, 2018 | ($447.3K) | Jan 11, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.54M) | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | ($101.8K) | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | ($544.8K) | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | ($2.43M) | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | ($3.15M) | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | ($2.21M) | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | ($1.77M) | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | ($343.1K) | Feb 28, 2020 |
| FY2019 | Oct 31, 2018 | ($1.82M) | Feb 28, 2020 |
| FY2018 | Oct 31, 2017 | ($1.77M) | Jan 11, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $396.59M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $142.22M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $190.37M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $217.03M | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $247.39M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $294.08M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $133.41M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $175.20M | Feb 28, 2020 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $320.5K | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $48.2K | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $66.6K | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $73.9K | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $248.5K | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $282.3K | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $136.5K | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $178.6K | Feb 28, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $0 | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $0 | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $0 | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $0 | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $0 | Feb 25, 2022 |
| FY2019 | Dec 31, 2019 | $0 | Feb 28, 2020 |
| FY2019 | Dec 31, 2018 | $0 | Feb 28, 2020 |
| FY2018 | Oct 31, 2018 | $0 | Jan 11, 2019 |
| FY2018 | Oct 31, 2017 | $0 | Jan 11, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Oct 31, 2017 | $151.89M | Jan 11, 2018 |
| FY2017 | Oct 31, 2016 | $154.89M | Jan 11, 2018 |
| FY2017 | Oct 31, 2015 | $181.77M | Jan 11, 2018 |
| FY2017 | Oct 31, 2014 | $202.98M | Jan 11, 2018 |
| FY2016 | Oct 31, 2013 | $281.58M | Jan 12, 2017 |
| FY2015 | Oct 31, 2012 | $333.08M | Jan 14, 2016 |
| FY2014 | Oct 31, 2011 | $567.64M | Jan 14, 2015 |
| FY2013 | Oct 31, 2010 | $353.23M | Jan 14, 2014 |
| FY2012 | Oct 31, 2009 | $369.72M | Jan 14, 2013 |
| FY2011 | Oct 31, 2008 | $467.00M | Jan 13, 2012 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | (1) | Feb 24, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | (1) | Feb 24, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Oct 31, 2015 | 1.85M | Jan 14, 2016 |
| FY2015 | Oct 31, 2014 | 2.00M | Jan 14, 2016 |
| FY2015 | Oct 31, 2013 | 2.60M | Jan 14, 2016 |
| FY2015 | Oct 31, 2012 | 3.15M | Jan 14, 2016 |
| FY2014 | Oct 31, 2011 | 4.55M | Jan 14, 2015 |
| FY2013 | Oct 31, 2010 | 3.50M | Jan 14, 2014 |
| FY2012 | Oct 31, 2009 | 3.80M | Jan 14, 2013 |